Healthcare dealmakers are heading to San Francisco betting on a new wave of mega-mergers in 2026 that could eclipse the industry’s standout years of 2019 and 2021 when such tie-ups approached half a trillion dollars, according to more than a dozen top bankers and lawyers. Ahead of the week-long 43rd annual J.P. Morgan Healthcare Conference, dealmakers said more forgiving antitrust scrutiny under U.S. President Donald Trump has given large pharmaceutical companies confidence to consider acquisitions worth $30 billion or even merging with equally big companies.
Read the full article: Healthcare Dealmakers Head to San Francisco Hoping for Megamergers in 2026 //
Source: https://www.msn.com/en-us/money/markets/healthcare-dealmakers-head-to-san-francisco-hoping-for-megamergers-in-2026/ar-AA1TUdGT